TY - JOUR
T1 - Young adult psychological outcome after puberty suppression and gender reassignment
AU - De Vries, Annelou L.C.
AU - McGuire, Jenifer K.
AU - Steensma, Thomas D.
AU - Wagenaar, Eva C.F.
AU - Doreleijers, Theo A.H.
AU - Cohen-Kettenis, Peggy T.
N1 - Publisher Copyright:
Copyright © 2014 by the American Academy of Pediatrics.
PY - 2014
Y1 - 2014
N2 - BACKGROUND: In recent years, puberty suppression by means of gonadotropin-releasing hormone analogs has become accepted in clinical management of adolescents who have gender dysphoria (GD). The current study is the first longer-term longitudinal evaluation of the effectiveness of this approach. METHODS: A total of 55 young transgender adults (22 transwomen and 33 transmen) who had received puberty suppression during adolescence were assessed 3 times: before the start of puberty suppression (mean age, 13.6 years), when cross-sex hormones were introduced (mean age, 16.7 years), and at least 1 year after gender reassignment surgery (mean age, 20.7 years). Psychological functioning (GD, body image, global functioning, depression, anxiety, emotional and behavioral problems) and objective (social and educational/professional functioning) and subjective (quality of life, satisfaction with life and happiness) well-being were investigated. RESULTS: After gender reassignment, in young adulthood, the GD was alleviated and psychological functioning had steadily improved. Wellbeing was similar to or better than same-age young adults from the general population. Improvements in psychological functioning were positively correlated with postsurgical subjective well-being. CONCLUSIONS: A clinical protocol of a multidisciplinary team with mental health professionals, physicians, and surgeons, including puberty suppression, followed by cross-sex hormones and gender reassignment surgery, provides gender dysphoric youth who seek gender reassignment from early puberty on, the opportunity to develop into well-functioning young adults.
AB - BACKGROUND: In recent years, puberty suppression by means of gonadotropin-releasing hormone analogs has become accepted in clinical management of adolescents who have gender dysphoria (GD). The current study is the first longer-term longitudinal evaluation of the effectiveness of this approach. METHODS: A total of 55 young transgender adults (22 transwomen and 33 transmen) who had received puberty suppression during adolescence were assessed 3 times: before the start of puberty suppression (mean age, 13.6 years), when cross-sex hormones were introduced (mean age, 16.7 years), and at least 1 year after gender reassignment surgery (mean age, 20.7 years). Psychological functioning (GD, body image, global functioning, depression, anxiety, emotional and behavioral problems) and objective (social and educational/professional functioning) and subjective (quality of life, satisfaction with life and happiness) well-being were investigated. RESULTS: After gender reassignment, in young adulthood, the GD was alleviated and psychological functioning had steadily improved. Wellbeing was similar to or better than same-age young adults from the general population. Improvements in psychological functioning were positively correlated with postsurgical subjective well-being. CONCLUSIONS: A clinical protocol of a multidisciplinary team with mental health professionals, physicians, and surgeons, including puberty suppression, followed by cross-sex hormones and gender reassignment surgery, provides gender dysphoric youth who seek gender reassignment from early puberty on, the opportunity to develop into well-functioning young adults.
KW - Adolescents
KW - Gender dysphoria
KW - Longitudinal outcomes
KW - Psychological functioning
KW - Puberty suppression
KW - Transgenderism
UR - http://www.scopus.com/inward/record.url?scp=84908521408&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908521408&partnerID=8YFLogxK
U2 - 10.1542/peds.2013-2958
DO - 10.1542/peds.2013-2958
M3 - Article
C2 - 25201798
AN - SCOPUS:84908521408
SN - 0031-4005
VL - 134
SP - 696
EP - 704
JO - Pediatrics
JF - Pediatrics
IS - 4
ER -